Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jillian M Baker

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Human Vaccines & Immunotherapeutics|June 6, 2023
Chimeric antigen receptor (CAR) T cells for the treatment of a kidney transplant patient with post-transplant lymphoproliferative disorder (PTLD)Kathryn Kline, Wengen Chen, Michael E Kallen, et al.
Cancer Immunology, Immunotherapy : CII|February 13, 2024
Treatment of secondary CNS lymphoma using CD19-targeted chimeric antigen receptor (CAR) T cellsKathryn Kline, Tim Luetkens, Rima Koka, et al.
Blood Advances|July 28, 2020
Fetal/neonatal alloimmune thrombocytopenia: a systematic review of impact of HLA-DRB3*01:01 on fetal/neonatal outcomeJens Kjeldsen-Kragh, Dean A Fergusson, Mette Kjaer, et al.
British Journal of Haematology|April 13, 2022
International guidelines regarding the role of IVIG in the management of Rh- and ABO-mediated haemolytic disease of the newbornLani Lieberman, Enrico Lopriore, Jillian M Baker, et al.
Haematologica|October 16, 2025
CNS infiltration by zamtocabtagene autoleucel tandem CD20/CD19 CAR T cells leading to complete remission in a patient with primary CNS lymphomaNancy M Hardy, Jean A Yared, Tim Luetkens, et al.
Blood Advances|July 26, 2024
What is in a name: defining pediatric refractory ITPTaizo A Nakano, Amanda B Grimes, Robert J Klaassen, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Human Vaccines & Immunotherapeutics|June 6, 2023
Chimeric antigen receptor (CAR) T cells for the treatment of a kidney transplant patient with post-transplant lymphoproliferative disorder (PTLD)Kathryn Kline, Wengen Chen, Michael E Kallen, et al.
Cancer Immunology, Immunotherapy : CII|February 13, 2024
Treatment of secondary CNS lymphoma using CD19-targeted chimeric antigen receptor (CAR) T cellsKathryn Kline, Tim Luetkens, Rima Koka, et al.
Blood Advances|July 28, 2020
Fetal/neonatal alloimmune thrombocytopenia: a systematic review of impact of HLA-DRB3*01:01 on fetal/neonatal outcomeJens Kjeldsen-Kragh, Dean A Fergusson, Mette Kjaer, et al.
British Journal of Haematology|April 13, 2022
International guidelines regarding the role of IVIG in the management of Rh- and ABO-mediated haemolytic disease of the newbornLani Lieberman, Enrico Lopriore, Jillian M Baker, et al.
Haematologica|October 16, 2025
CNS infiltration by zamtocabtagene autoleucel tandem CD20/CD19 CAR T cells leading to complete remission in a patient with primary CNS lymphomaNancy M Hardy, Jean A Yared, Tim Luetkens, et al.
Blood Advances|July 26, 2024
What is in a name: defining pediatric refractory ITPTaizo A Nakano, Amanda B Grimes, Robert J Klaassen, et al.
Pageof 3